ERBB2 and colorectal carcinoma: The biological and clinical roles of HER2 activation still need to be investigated in the pathogenesis of CRC and its association with tumor behavior, prognosis, and responses to chemotherapy, as well as with potential anti-HER2-targeted therapies14.